BDBM714797 6-benzyl-4-((5-(2,4-difluoro-3- hydroxy-5-(trifluoromethyl)phenyl)- 1,3,4-thiadiazol-2-yl)methyl)-4,6- diazaspiro[2.4]heptane-5,7-dione::US20250026745, Compound I-57

SMILES O=C1N(Cc2ccccc2)C(=O)C2(CC2)N1Cc1nnc(-c2cc(C(F)(F)F)c(F)c(O)c2F)s1

InChI Key InChIKey=SHASGMPPERNDFC-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 714797   

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Bluejay Therapeutics

US Patent
LigandPNGBDBM714797(6-benzyl-4-((5-(2,4-difluoro-3- hydroxy-5-(trifluo...)
Affinity DataIC50: 2.46nMAssay Description:More specifically, recombinant 17β-HSD13 protein was assayed in a buffer containing 200 mM Tris pH 7.5, 0.01% Triton X-100, and 0.02% BSA into a 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent